C. Bancroft

IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas

G. Dong, C. Waes, Zhong Chen, 2001 .

IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.

C. Van Waes, G. Dong, N. Yeh, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.

C. Van Waes, G. Dong, C. Waes, 2001, Cancer research.

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines

C. Van Waes, Zhong Chen, J. Yeh, 2002, International journal of cancer.

IL‐12‐ and IL‐2‐induced tumor regression in a new murine model of oral squamous‐cell carcinoma is promoted by expression of the CD80 co‐stimulatory molecule and interferon‐γ

C. Van Waes, Zhong Chen, I. Enamorado, 2000, International journal of cancer.

Hepatocyte Growth Factor / Scatter Factor-induced Activation of MEK and PI 3 K Signal Pathways Contributes to Expression of Proangiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor in Head and Neck Squamous Cell Carcinoma 1

G. Dong, C. Waes, Zhong Chen, 2001 .

IL (Interleukin)-1a Promotes Nuclear Factor-kB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas

G. Dong, C. Waes, Zhong Chen, 2001 .

Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.

C. Van Waes, G. Dong, C. Waes, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.

Z Chen, E. Sausville, P. Elliott, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.